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Abstract The expression of epidermal growth factor (EGF) and transforming growth factor-a (TGF-a) mRNA in the small intestine of suckling 
and adult rats was examined by in situ hybridization. EGF mRNA was found mainly in the intestinal crypts in adult rats. Adult rats also exhibited 
a considerably stronger signal for EGF mRNA in comparison to suckling rats, where the signal was very low or absent. In contrast to EGF, very 
strong expression of TGF-a mRNA was observed in the small intestine of both adult and suckling rats. These data suggest he differences between 
the expression of EGF and TGF-a in the developing small intestine. 
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1. Introduction 
The gastrointestinal epithelium undergoes a continuing proc- 
ess of cell proliferation, differentiation and maturation. Rap- 
idly proliferating crypt enterocytes migrate from the crypts to 
the villus tip, losing their proliferative capacity and increasing 
their differentiation capability. The mechanisms that regulate 
and coordinate this rapid turnover are not clear, but a number 
of observations suggests that hormones and peptide growth 
factors are an essential part of this regulatory system. Two 
growth factors that are thought to play an important role in this 
process are epidermal growth factor (EGF) and transforming 
growth factor-a (TGF-cc); mitogenic peptides that share 33% 
structural homology [l] and bind to the same cell surface TGF- 
alEGF receptor [2,3]. 
EGF has been detected in many tissues and body fluids, 
including salivary and gastrointestinal secretions, colostrum 
and milk, and amniotic fluid. It has been shown that EGF has 
widespread effects on growth, cell proliferation and maturation 
of a variety of tissues [4], including fetal, neonatal and adult 
gastrointestinal epithelium [5-111, as well as on gastric acid 
secretion [12]. EGF was first isolated from the submandibular 
glands (SMG) of the adult male mouse by Cohen [13], and its 
amino acid sequence was determined by Savage et al. [14]. 
Although EGF gene expression has been detected in various 
organs, the highest level of expression of EGF mRNA has been 
found in the male SMG and kidney [15]. Localization of EGF 
mRNA transcripts in these organs from rodents has been dem- 
onstrated using in situ hybridization [15-201. 
TGF-a was initially considered an embryonic growth factor 
[21,22], but it is now accepted as an integral regulator of growth 
in normal tissues [23,24]. Localization of TGF-a mRNA using 
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in situ hybridization has been reported in rodent maternal de- 
cidua and fetal tissues [25-271. Both TGF-a peptide and TGF-a 
mRNA have also been found in the human fetal and adult 
gastrointestinal tract [28-311 and in the human fetal pancreas 
1321. 
In rodents, EGF and TGF-a peptides have been reported in 
the gastrointestinal tract of adult, as well as in suckling animals 
[33-361. Immunohistochemical studies have detected EGF pep- 
tide in the Brunner’s gland of the duodenum and the Paneth 
cells of the small intestine of adult rats [37], whereas im- 
munoreactive TGF-a has been localized in the villus but not in 
the intestinal crypts [35,38]. An abundance of TGF-a mRNA 
was found in the gastrointestinal tract of adult rodents, whereas 
EGF mRNA was not detected in the gastrointestinal tract of 
either adults [30,35,39] or sucklings [40]. Recently, Miettinen 
reported the presence of EGF mRNA in the developing human 
fetal gastrointestinal tract using ribonuclease protection assay 
and polymerase chain reaction analysis [41]. 
Based on these observations, we decided to test whether 
developing rat gastrointestinal tissue itself has the capability to 
produce EGF and TGF-a peptides. The main goal of this study 
was to clarify the presence of EGF mRNA and TGF-a mRNA 
in the developing rat small intestine. In order to detect these 
transcripts, we initially established a sensitive in situ hybridiza- 
tion technique for detection of EGF mRNA in rat male sub- 
mandibular glands. This technique was then used for detection 
and localization of EGF and TGF-a mRNA in the small intes- 
tine of suckling as well as adult male rats. Some of the results 
were recently presented at the American Gastroenterological 
Association meeting [42]. 
2. Materials and methods 
2.1. Tissue preparation 
Sprague-Dawley male rats bred in our colony were used in this 
experiment. Rats had unlimited access to drinking water and a standard 
laboratory diet (Lab Blox, TechLab, Indianapolis, IN). Ten adult 70- to 
IO-day-old male rats (45&520 g) and fifteen suckling 12-day-old male 
rats (31-35 g), each group originally from five different litters, were 
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killed by decapitation and the duodenum, jejunum (first third of the 
jejunoileum) and submandibular glands quickly removed. The organs 
were embedded in OCT compound (Tissue Tek II, Miles, Elkhart, IN), 
snap-frozen in liquid nitrogen and stored at -70°C. 8-pm thick sections 
were cut with a cryostat and mounted on glass slides coated with 
poly+lysine (Sigma Co., St. Louis, MO). 
2.2. Probes 
A 784 bp ApaIlSpeI fragment of mouse EGF cDNA inserted into 
plasmid pGE&f-5Z-and a 925 bp EcoRI fragment of human TGFa 
cDNA inserted into olasmid uGEM-1 were kindlv nrovided bv Dr. R. 
Coffey, of Vanderbili Univeriity, Nashville, TN. ?he pGEM-;Z plas- 
mid was linearized either by using SaZI restriction endonuclease to 
generate the appropriate template for EGF antisense RNA probe, or 
by using ApaI restriction endonuclease for the EGF sense RNA probe. 
The pGEM-1 plasmid was linearized either by using Hind111 to generate 
a template for the TGF-a antisense RNA probe or by using PvuII for 
the TGF-a sense RNA probe. All restriction endonucleases were from 
Boehringer-Mannheim, Indianapolis, IN. A non-radioactive technique 
was used for labeling the RNk probes. Digoxigenin-labeled (DIG- 
labeled) UTP was included in the nucleotide mixture and RNA nrobes 
were generated by in vitro transcription from linearized cDNA tem- 
plates using the RNA Labeling Kit (Boehringer-Mannheim) according 
to the standard manufacturer’s protocol. T7 RNA polymerase was used 
to synthesize EGF or TGF-a antisense RNA probes, while SP6 RNA 
polymerase gave EGF or TGF-a sense RNA probes. Digoxigenin in- 
corporation was measured by dot blot analysis of serial dilutions of the 
probes. The amount of RNA transcribed was determined by comparing 
serial dilutions with a standard RNA solution. 
2.3. In situ hybridization 
All treatments with sections, prehybridization, hybridization and 
washing steps were derived from the protocols of Salido et al. [17] and 
Couwenhoven et al. [19]. Recently, Viaene and Baert [43] used a similar 
protocol for non-isotopic in situ hybridization in human esophageal 
mucosa. All solutions were prepared with diethylpyrocarbonate-treated 
water. Tissue sections from suckling and adult rats were assayed simul- 
taneously under the same reaction-conditions. The cryoseciions were 
first treated with 1 .&ml of proteinase K in 50 mM Tris-HCl (pH 7.5), 
5 mM EDTA, at 37°C for 7 min. After rinsing with phosphate buffered 
saline (PBS), pH 7.4, containing 2 ,ug/ml of glycine, the sections were 
nost-fixed with 4% (w/v) uaraformaldehvde (PFA) in PBS for 5 min. 
The slides were thed r&d with PBS containing i &ml glycine and 
with 0.2 x SSC (1 x SSC is 150 mM sodium chloride, 15 mM sodium 
citrate, pH 7.0). After 5 min incubation in 0.1 M triethanolamine (TEA) 
buffer (pH 8.0), the sections were treated in TEA buffer with 0.25% 
(v/v) acetic anhydride for 10 min and then washed in 2 x SSC for 10 
min. After dehydration through an ascending ethanol series, the hybrid- 
ization buffer containing 50% formamide, 0.75 M NaCI, 25 mM 
EDTA, 1 x Denhardt’s olution, 0.1 M dithiothreitol (DTT), 0.2% so- 
dium dodecyl sulfate (SDS), and 100 @ml yeast transfer RNA, with 
the addition of heat denatured herring sperm DNA at 300 pglml, was 
applied to each section and slides were prehybridized at 37°C for 2 h. 
All chemicals were purchased from Sigma Co. After prehybridization, 
the hybridization buffer was removed and 25 ~1 of hybridization buffer 
(without herring sperm DNA) containing 50 ng/pl EGF, or TGF-cr 
DIG-labeled antisense or sense RNA probes (for control sections) were 
added to each section, which were then coverslipped and the slides 
incubated in a moist chamber at 4548°C overnight. After hybridiza- 
tion coverslips were gently removed by immersion in 4 x SSC. The 
slides were incubated for 30 min at 37’C with 50 @ml RNase A in 0.5 
M NaCl, 10 mM Tris-HCl (PH 7.5), and 1 mM EDTA to digest any 
unhybridized probe. The slides were then washed with 2 x SSC for 30 
min at room temperature, 0.2 x SSC for 15 min at 42’C, 0.1 x SSC for 
15 min at 42”C, and 0.1 x SSC for 10 min at room temperature. Hybrid- 
ized probes were immunologically detected with the alkaline phosphat- 
ase-coupled anti-digoxigenin antibody, by using the Nucleic Acid De- 
tection Kit (Boehringer-Mannheim) according to the standard manu- 
facturer’s protocol. The stable color precipitates were developed by the 
reaction of alkaline phosphatase with Nitroblue tetrazolium chloride/5- 
bromo-4-chloro-3-indolyi phosphate and levamisole. Levamisole was 
included to inhibit the activity of endogenous phosphatases. The sec- 
tions were then counterstained with hematoxylin and permanently cov- 
ered with coverslips using ACCU Mount 60 Mounting Medium 
(Baxter, Scientific Products, McGaw Park, IL) and stored in the dark. 
3. Results 
3.1. EGF 
To determine that the in situ hybridization technique was 
specific and provided results consistent with those in the litera- 
ture, we performed in situ hybridization on sections of the 
submandibular glands from the adult male rats. The sections 
that hybridized with the DIG-labeled EGF antisense RNA 
probe demonstrated an intensely positive signal in the granular 
convoluted tubule cells, whereas hybridization with the EGF 
sense (control) probe resulted in only a background level over 
these cells (figures not shown). After these verification experi- 
ments, in situ hybridization was performed on small intestinal 
sections from adult and suckling rats. 
In adult male rats, when the EGF antisense RNA probe was 
applied to sections of the duodenum and jejunum, an intense 
positive staining was evident in the cytoplasm of the intestinal 
crypt cells (Fig. 1A). The enterocytes of the lower half of the 
villi also gave a positive signal for the presence of EGF mRNA. 
No staining was observed in the upper part of the villi or in the 
lamina propria. The sense probe yielded only a uniform back- 
ground signal (Fig. 1B). 
Previous studies have implicated a role for exogenous milk- 
borne EGF in growth and development of the intestine [33,34]. 
To determine the potential contribution of endogenous EGF, 
we performed in situ hybridization for EGF mRNA in lZday- 
old suckling male rats. Tissues from duodenum or jejunum of 
suckling rats usually showed no staining throughout all sec- 
tions. In some cases (one from five animals), a low expression 
of EGF mRNA was observed in the intestinal crypt enterocytes 
(Fig. 2A); however, no signal was detected in the cells of the 
villi. Hybridization with the sense EGF probe resulted in only 
uniform background labeling (Fig. 2B). 
3.2. TGF-a 
To determine the site of expression of the TGF-a mRNA, 
in situ hybridization for TGF-a mRNA was performed on the 
Fig. 1. In situ hybridization of EGF and TGF-a mRNA with the DIG-labeled RNA probes in the adult male rat jejunum. (A) Strong positive signal 
for the presence of EGF mRNA is in the crypt cells. Enterocytes of the lower half of the villi also exhibit a positive signal (x 140). (B) Hybridization 
with the EGF sense probe yields only a uniform background signal (x 140). (C) The expression of TGF-a mRNA. Very strong staining appears in 
the crypt cells and in the enterocytes of the lower two-thirds of the villi. The tips of the villi exhibit a weak staining (x 140). 
Fig. 2. In situ hybridization of EGF and TGF-a mRNA with the DIG-labeled RNA probes in rat jejunum from suckling (12-day-old) male rat. 
(A) In some rats (one out of five) a low positive signal for the presence of EGF mRNA appears in crypt cells. The enterocytes of the villi are not 
stained (x 180). (B) Control EGF sense probe shows only a uniform background signal (x 180). (C) Strong positive staining for the presence of TGF-a 
mRNA is present in the intestinal crypt cells (x 180). 
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same sections as for EGF. Application of the DIG-labeled 
TGF-d antisense RNA probe to the adult male rat duodenum 
and jejunum resulted in very strong staining throughout the 
intestinal crypts (Fig. 1C). In addition, a very strong signal was 
also observed in enterocytes of the lower two-thirds of the villi 
with reduced staining intensity to the tips of the villi. Entero- 
cytes at the villus tip exhibited weaker, but still well detectable 
staining (not shown). The sense probe gave only a uniform 
background signal which was similar to that seen with the EGF 
sense probe (Fig. 1B). 
Previous studies have indicated the presence of TGF-a 
mRNA in adult rat intestine [30,35,39]. We have previously 
shown that TGF-a peptide is absent in rat milk [36], but the 
peptide is detectable throughout the gastrointestinal tract of 
suckling rats. To determine the possible sources of TGF-a in 
the developing gastrointestinal tract, we also performed in situ 
hybridization using the TGF-a probe in the small intestine of 
suckling rats. These experiments howed an intensely positive 
signal for the presence of TGF-a transcripts in the crypt cells 
of duodenum and jejunum from suckling rats (Fig. 2C). Incuba- 
tion with the sense probe resulted in only uniform low back- 
ground labeling. 
4. Discussion 
Our studies using the in situ hybridization technique with 
non-radioactive DIG-labeled RNA probes clearly show the 
expression of both EGF and TGF-a transcripts in the crypt 
enterocytes of adult male rats. The presence of TGF-a mRNA 
was detected in the enterocytes of the whole villi, whereas the 
expression of EGF mRNA was observed only in the entero- 
cytes from the lower part of the villi. The intensity of staining 
suggested much higher abundance of TGF-a mRNA in com- 
parison with EGF mRNA. In suckling male rats, crypt cells 
gave an intense signal for TGF-a mRNA, whereas the EGF 
mRNA signal was either very low or, more often, no signal was 
observed at all. 
EGF and TGF-a have long been regarded as likely modula- 
tors of gastrointestinal epithelial growth and differentiation 
[6-l 1,28,29,39,4446]. The structural similarity and functional 
resemblance of these two growth factors have suggested similar 
origins and fates in the gastrointestinal tract. However, previ- 
ous reports from our laboratory have shown significant differ- 
ences between these two growth factors. Both peptides are 
present in the gastrointestinal tract of suckling and adult rats, 
but EGF, which is present in milk from several mammalian 
species including rat milk [47], belongs to the group of milk- 
borne biologically active peptides [48]. EGF levels in the gastro- 
intestinal tract of sucklings are significantly higher than in 
adults [33] and are dependent on EGF intake [34]. Interestingly, 
suckling rats fasted overnight or hand fed for 3 days with 
EGF-free rat milk substitute kept some EGF content in the 
small intestine (about 15% of the initial level) [49]. This could 
either be interpreted as an effect of adrenal stimulation or be 
the result of local production of EGF in the small intestinal 
tissue. 
On the other hand, TGF-a peptide has not been found in rat 
milk, and its small intestinal levels are similar in both suckling 
and adult rats [36]. Barnard et al. [35] studied the distribution 
of TGF-a mRNA and TGF-a peptide in the small intestine of 
adult rats. They found that TGF-a mRNA was evenly ex- 
pressed along the jejunal crypt-villus axis, whereas TGF-a 
immunoreactivity was detected only along the villus. The au- 
thors postulated that TGF-a produced in the jejunal epithelium 
may not only stimulate cell proliferation, but also affect the 
migration of enterocytes to the top of the villus. Alison et al. 
[38] recently reported a similar pattern of staining with TGF-a 
antibodies in adult rat jejunum; a strong signal was detected in 
the surface of villus, but the crypt cells were totally unstained. 
The exact locus, as well as the biological function, of TGF-a 
within the small intestine, are not completely known, but the 
strong signal for TGF-a mRNA was detected in IEC-6 cells, 
a cell line thought to be derived from rat intestinal crypt cells 
[35,39]. While the expression of TGF-a mRNA in the gastroin- 
testinal tract of adult rats was repeatedly reported [30,35,39]; 
at the same time EGF mRNA was not detectable. In these 
studies, Northern blot was used for detection of mRNA tran- 
scripts in the enterocyte fractions eluted from the small intes- 
tine. Miettinen [41] has shown that the xpression of TGF-a 
mRNA in the human fetal small intestine was more abundant 
than EGF mRNA. The presence of EGF mRNA was detecta- 
ble only by using RNase protection assay or polymerase chain 
reaction analysis, the sensitivity of Northern blot analysis was 
insufficient to detect any EGF transcripts. It was also specu- 
lated that EGF mRNA has not been previously detected in the 
gastrointestinal tract because of the insensitivity of the methods 
used. Other findings of interest were that in the jejunum, ex- 
ogenous EGF peptide up-regulated TGF-a mRNA expression 
3-fold, whereas exogenous TGF-a reduced its own mRNA by 
40% [41]. Similar results were observed with the rat intestinal 
cell line IEC-6, where the addition of EGF peptide to culture 
medium significantly increased TGF-a mRNA expression [50]. 
In the present study, a sensitive method that was specific for 
the in situ cytological localization of EGF mRNA and TGF-a 
mRNA in the small intestine of suckling and adult rats was 
used. EGF mRNA transcripts were detected mainly in intesti- 
nal crypt cells. The variations seen in the intensity of staining 
also permit comparisons of the abundance of the message fog 
EGF between suckling and adult rats. Duodenum and jejunum 
from adult rats exhibited a significantly stronger signal in com- 
parison with sucklings, where a very low or no signal was 
observed. These observations invite speculation that milk- 
borne EGF reduces EGF mRNA expression in the gastrointes- 
tinal tract in suckling rats. 
In contrast to EGF, strong expression of TGF-a mRNA was 
observed in the small intestine of both suckling and adult rats. 
These findings support our previous results where we found 
that TGF-a peptide is present in similar concentrations in the 
small intestinal mucosa from suckling and adult rats, and over- 
night fasting did not significantly affect these levels in sucklings 
[36]. Moreover, in suckling rats, 90% of immunoreactive TGF- 
a from the total content of intestinal lumen and mucosa was 
found in the mucosa, suggesting intestinal tissue as a site of 
TGF-a peptide synthesis. On the other hand, mucosal EGF 
peptide in suckling rats represents only 25-60% of its total 
intestinal content [33,34]. 
This study demonstrates the expression of EGF and TGF-a 
mRNA in the small intestine of adult rats. It is noteworthy that 
in sucklings, a high content of EGF in rat milk corresponds to 
very low expression of intestinal EGF mRNA, whereas the 
absence of TGF-a in rat milk is accompanied by high concen- 
trations of TGF-a mRNA in the same tissue. 
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